Rachel Palmer, Pharmacy Lead for Genomic Medicine Service Alliance in the South West, and Helen Winter, Medical Oncologist at University Hospitals Bristol and Weston NHS Trust, were the Associate Principal Investigator (PI) and PI for the Molecular Genetics of Adverse Drug Reactions (MOLGEN) study.
Both Rachel and Helen had a positive experience of the Associate PI Scheme. In this video they explain how the scheme was beneficial to them and for the success of the study.
Find out more about the Associate PI Scheme and how to get involved at [ Ссылка ]
Full video transcript: [ Ссылка ]
Subscribe to the NIHRtv YouTube channel at [ Ссылка ]
Follow NIHR on social media
• Twitter [ Ссылка ]
• Facebook [ Ссылка ]
• LinkedIn [ Ссылка ]
